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min at each dose in 5 class IV heart 
patients (CHF) and 5 normal (Nl) skbjects. 1.11 
subjects received a 10 ml/kg wa 
had steady-state infusions of P 
and urine flow was replaced with D5 i/2 MS i.v. 
CHF patients had higher 
vs 24+5, pcO.001) and lowe 
(294+18 vs 459 + 57 ml/min, ~~0.05) at baseline 
than Nl subjects. At the highest dose of 
infusion, plasma ANF (Nl: 1105+147, CHF: 1 
159 pg/ml P=NS) and cGP4P (Nl: 22.8~1.1, CHF: 
50.2G7.6 pmol/ml P-NS), and urinary cGW rose 
significantly. Urine flow rate increased from 
2.220.6 to 7.1k3.4 ml/min in CHF and 6.621.2 to 
25.7~6.3 in Nl (~~0.05). Sodium excretion rose 
from 1724 to 2322163 uEg/min in CHF and 211219 
to 13672179 in Nl (~~0.05) and fractional sodi- 
um excretion rose from 0.5*0.1 to 
CHF vs 0.9+0.1 to 5.8+8 an Iv1 (p 
ERPF, GFR and filtration fraction 
change. 
We conclude that vere CHF patients exhibit 
renal responses to F which are similar ih 
proportion, but reduced in absolute magnitude 
when compared with normal subjects. The renal 
changes seen in CHF are similar to those noted 
in N1 wbjects following a mild oral water 
load. 
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Nitraees are co only used in ereatmene of chronic heart 
failure (CHF). However, their hemodynamic effect when 
given concomitantly eo angiotensin converting enzyme 
inhibit ior (ACEI? s has not been invesefgated. We studied 
the effect of GO mg oral isosorbide dinitrate (ISDE;) in 
11 patienes (pts) with CHF chronically treated with 
captopril (CAP) 89+32mgl day. Mearl pulmonary arterial 
(PA) e pulmonary wedge (PAW) and right atria1 (&I) 
pressures (mm Hg) were studied on CAP alone and 26 hrs 
later on CAF’+ISDN. Nemodynamic values were as follows: 
PA 
-  I_ 
CAP 3828 3720 3m 3ITz-- 
C+ISDN 38’7 3oz?0* 32?6* 33+8* 
PAW CAP 24?6 2226 2427 2527 
C+JSDh’ 24*7 16?6& 18%9* 20t9* 
RA CAP 1126 1125 1226 1225 
C+ISDN 1225 t3+3* 1024 9+4* 
Addition of ISDN to CAP resulted in no significant 
change in blood pressure (BP). 
CONCLUSIONS : I) ISDN potentdates h 
captopril on RA, PA and PAW without change in BP. 2) 
The reduction of right and left ventricular f ifling 
pressures and pulmonary hypertension demonstrates the 
therapeutic potential of mmbinaeion therapy with 
nitrates + ACE1 in pts with chronic CAF. 
